Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 8 of the 30 sources its claims cite were checked for support.

The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial

Open access

Published version of a preprint

Abstract

BACKGROUND: Self-management of hypertension is of great significance given its increasing incidence and its associated disabilities. In view of the increased use of mobile health in medicine, the present study evaluated the effect of a self-management application on patient adherence to hypertension treatment. METHODS: This clinical trial was performed on 120 hypertensive patients who were provided with a mobile intervention for 8 weeks and followed up until the 24th week. Data on the primary outcome (adherence to treatment) and secondary outcomes (adherence to the DASH diet, regular monitoring of blood pressure, and physical activity) were collected using a questionnaire and a mobile application, respectively. The inter-group change difference over time was analyzed using repeated measures ANOVA (general linear model). RESULTS: The treatment adherence score increased by an average of 5.9 (95% CI 5.0-6.7) in the intervention group compared to the control group. The scores of "adherence to the low-fat and low-salt diet plans" were 1.7 (95% CI 1.3-2.1) and 1.5 (95% CI 1.2-1.9), respectively. Moreover, moderate physical activity increased to 100.0 min (95% CI 61.7-138.3) per week in the intervention group. CONCLUSION: The treatment and control of blood pressure require a multifaceted approach given its complexity and multifactorial nature. Considering the widespread use of smartphones, mHealth interventions can be effective in self-management and better patient adherence to treatments. Our results showed that this application can be used as a successful tool for hypertension self-management in patients attending public hospitals in developing countries. TRIAL REGISTRATION: Iran Randomized Clinical Trial Center IRCT2015111712211N2 . Registered on 1 January 2016.

Overview

CoChat Summary

TL;DR

This randomized controlled trial evaluated a mobile Blood Pressure Management Application (BPMAP) added to routine care in 120 Iranian adults with primary hypertension. Over 24 weeks, the intervention improved medication adherence, diet adherence, blood pressure, and physical activity compared with usual care.

Key findings

  • Medication adherence on the Hill-Bone Scale improved by 5.9 points (95% CI 5.0–6.7) in the intervention group compared with the control group.
  • Adherence to low-fat and low-salt diet plans increased by 1.7 points (95% CI 1.3–2.1) and 1.5 points (95% CI 1.2–1.9), respectively.
  • Moderate physical activity increased by 100.0 min per week (95% CI 61.7–138.3), and mean arterial pressure decreased by 3.4 mmHg (95% CI 1.6–5.2) in the intervention group compared with control.
  • Among app users, 84.7% (50 people) recorded blood pressure more than 25 times over 2 months; mean satisfaction with the app was 18.41 on a 1–20 scale.

Methods

  • Randomized, controlled clinical trial with two parallel arms; 120 patients with primary hypertension, aged 30–60, attending Tehran Heart Center in Iran, were allocated 1:1 using permuted block randomization (block size 4).
  • Intervention participants received BPMAP plus routine treatment; control participants received usual care. Follow-up included visits at 2-week intervals and final assessment at 24 weeks, with outcomes measured at baseline, 8 weeks, and 24 weeks.
  • Primary outcome was antihypertensive medication adherence measured by the 14-item Hill-Bone Scale; secondary outcomes included DASH diet adherence, sodium/fat intake, blood pressure monitoring, physical activity, and PRECEDE factors. Analysis used repeated measures ANOVA/general linear model adjusted for baseline scores in SPSS 20.0.

Limitations

  • The authors state the study was not blinded, relied on self-report questionnaires and app-recorded measurements, and required participants to own an Android smartphone.
  • The authors also note that positive attitudes among consultant physicians or participants toward the app could have inclined them to detect or express positive results.
  • The text makes evident that two intervention participants were lost to follow-up due to emigration and irregular attendance, and baseline characteristics show some between-group differences (e.g., mean arterial pressure 108.0 vs 114.9 mmHg; cholesterol 179.8 vs 196.7 mg/dl).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13063-021-05270-0

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Trial flow diagram. The procedure of the study evaluating the impact of the Blood Pressure Management Application (BPMAP)
Fig. 1 Trial flow diagram. The procedure of the study evaluating the impact of the Blood Pressure Management Application (BPMAP)CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 11 Not checked · 39 Own results and interpretations

23 more claims

Create a free account to see all 56 claims and to verify the 22 references still open.

See all claims — free account
  • It may state two separate claims as one. 12
  • The quote only partly states this claim. 2
  • Probably not a substantial claim. 20

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 34 references

Cited by

See all 94

Metadata

Authors
Bozorgi, A., Hosseini, H., Eftekhar, H., Majdzadeh, R., Yoonessi, A., Ramezankhani, A., Mansouri, M., & Ashoorkhani, M.
Affiliations
  • Tehran Heart Center (IR)
  • Tehran University of Medical Sciences (IR)
  • Payame Noor University (IR)
Corresponding author
Ashoorkhani, Mahnaz
Venue
Trials
Published
2021-06-24
Volume
22
Issue
1
Pages
413-413
ISSN
1745-6215 (ISSN-L)
OpenAlex
W3111671800
Cited by
94
References
34
Citations by year
2026: 9 · 2025: 15 · 2024: 40 · 2023: 18 · 2022: 11 · 2021: 1
FWCI
19.66
Type
journal article
Language
en
Open access
Licence
Locations
  • Trials (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Open Access at Essex (University of Essex) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
The Global Oper Reserch Support Team (00990476)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Keywords
hypertension, self-management, mobile health, mobile health apps, medication adherence, DASH diet, blood pressure monitoring, physical activity, smartphone-based intervention
MeSH terms
Self-Management, Blood Pressure, Humans, Hypertension, Iran, Medication Adherence, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial. https://app.cochat.ai/papers/10.1186/s13063-021-05270-0
The paper
Bozorgi, A., Hosseini, H., Eftekhar, H., Majdzadeh, R., Yoonessi, A., Ramezankhani, A., Mansouri, M., & Ashoorkhani, M. (2021). The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial. Trials. https://doi.org/10.1186/s13063-021-05270-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.